Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-21T23:29:44.308Z Has data issue: false hasContentIssue false
  • English
  • Français

Bloodstream Infections in a Neonatal Intensive-Care Unit: 12 Years' Experience With an Antibiotic Control Program

Published online by Cambridge University Press:  02 January 2015

Leandro Cordero ,
Mercedes Sananes  and
Leona W. Ayers
Leandro Cordero*
Affiliation:
Department of Pediatrics, The Ohio State University Medical Center, Columbus, Ohio
Mercedes Sananes
Affiliation:
Department of Pediatrics, The Ohio State University Medical Center, Columbus, Ohio
Leona W. Ayers
Affiliation:
Allied Medical Professions, The Ohio State University Medical Center, Columbus, Ohio
*
Director of Newborn Services, Professor of Pediatrics and Obstetrics, The Ohio State University Medical Center, Pediatrics Department, N118 Doan Hall, 410 W 10th Ave, Columbus, OH 43210-1228
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To assess the prevalence of gram-positive coccal (GPC), gram-negative bacillary (GNB), and fungal bloodstream infections (BSIs) during a 12-year period in which a consistent antibiotic treatment protocol was in place; to evaluate the efficacy of these antibiotic policies in relation to treatment, to the emergence of bacterial or fungal resistance, and to the occurrence of infection outbreaks or epidemics.

Study Design:

Case series.

Methods:

Demographic, clinical, and bacteriological information from 363 infants born during 1986 through 1991 and 1992 through 1997 who developed 433 blood-culture-proven BSIs was analyzed. Early-onset BSIs were defined as those infections discovered within 48 hours of birth, and late-onset BSIs as those that occurred thereafter. Suspected early-onset BSIs were treated with ampicillin and gentamicin, and suspected late-onset BSIs with vancomycin and gentamicin. Antibiotics were changed on the basis of organism antimicrobial susceptibility.

Results:

Early-onset BSIs were noted in 52 of 21,336 live births and 40 of 20,402 live births during 1986 through 1991 and 1992 through 1997, respectively. GPC (83% due to group B streptococcus [GBS]) accounted for approximately one half of early-onset BSI cases and GNB (68% Enterobacteriaceae) for the remainder. Early-onset GBS declined from 24 to 11 cases (P =.04) and late-onset BSI increased from 111 to 230 cases (P<.01) from the first to the last study period. Sixty-eight percent of late-onset BSIs were due to GPC (primarily coagulase-negative Staphylococcus), 18% to GNB, and 14% to fungus. Over the study period, Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa isolated from the newborn intensive-care unit (unlike those strains from other hospital units) remained fully susceptible to ceftazidime and gentamicin. Although the hospitalwide prevalence of methicillin-resistant Staphylococcus aureus increased, all 17 newborn BSI cases were due to methicillin-sensitive strains. Prevalence of methicillin-resistant coagulase-negative Staphylococcus increased, although all strains remained vancomycin-susceptible, as did the 16 Enterococcus faecalis isolates. All fungi recovered (from 48 patients) were susceptible to amphotericin.

Conclusion:

We observed a decrease in the prevalence of early-onset BSIs due to GBS and an increase in late-onset BSIs due to GPC, GNB, and fungi. The combination of ampicillin and gentamicin for suspected early-onset BSIs and vancomycin and gentamicin for late-onset BSIs has been successful for treatment of individual patients without the occurrence of infection outbreaks or the emergence of resistance. Controlled antibiotic programs and periodic evaluations based on individual unit and not on hospitalwide antibiograms are advisable.

Type
Orginal Articles
Information
Infection Control & Hospital Epidemiology , Volume 20 , Issue 4 , April 1999 , pp. 242 - 246
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Moore, DL. Nosocomial infections in newborn nurseries and neonatal intensive care units. In: Mayhall, CG, ed. Hospital Epidemiology and Infection Control. Baltimore, MD: Maple Press; 1996:535–564.Google Scholar
2.Peter, G, Cashore, WJ. Infections acquired in the nursery: epidemiology and control. In: Remington, JS, Klein, JO, eds. Infectious Diseases of the Fetus and Newborn Infant. 4th ed. Philadelphia, PA- W.B. Saunders Co; 1995:1264–1286.Google Scholar
3.Freeman, J, Epstein, MF, Smith, NE, Platt, R, Sidebottom, DG, Goldmann, DAExtra hospital stay and antibiotic usage with nosocomial coagulase-negative staphylococcal bacteremia in two neonatal intensive care unit populations. Am J Dis Child 1990;144:324–329.Google ScholarPubMed
4.Simon, C, Schröder, H, Beyer, C, Zerbst, T. Neonatal sepsis in an intensive care unit and results of treatment. Infection 1991;19:146–149.CrossRefGoogle Scholar
5.Tessin, I, Trollfors, B, Thiringer, K, Larsson, RAmpicillin-aminoglycoside combinations as initial treatment for neonatal septicemia or meningitis. Acta Paediatr 1991;80:911–916.CrossRefGoogle ScholarPubMed
6.Dobson, SRM, Isaacs, D, Wilkinson, AR, Hope, PLReduced use of surface cultures for suspected neonatal sepsis and surveillance. Arch Dis Child 1992;67:44–47.CrossRefGoogle ScholarPubMed
7.Kalenic, S, Francétic, I, Polak, J, Zele-Starcevic, L, Bencic, Z. Impact of ampicillin and cefuroxime on bacterial colonization and infection in patients on a neonatal intensive care unit J Hosp Infect 1993;23:35–41.CrossRefGoogle ScholarPubMed
8.Moller, JC, Rossa, M, Nachtrodt, G, Richter, ATegtmeyer, FKPreventive antibiotic administration for prevention of nosocomial septicemia in very small premature infants—preventive vancomycin administration against infections with coagulase-negative streptococci—prevention of translocation with oral Cefixime therapy in intestinal colonization with pathogenic gram-negative pathogens. Klin Padiatr 1993;205:140–144.Google ScholarPubMed
9.Van Heijst, AFJ, Sauerwein, RW, Hoogkamp-Korstanje, JAKollée, LAAPrevention of nosocomial infections with amoxicillin/clavulanic acid in artificially ventilated preterm infants. Prenatal and Neonatal Medicine 1997;2:343–347.Google Scholar
10.Pillay, XPillay, DG, Adhikari, M, Sturm, AW. Piperacillin/Tazobactam in the treatment of Klebsiella pneumoniae infections in neonates. Am J Perinatol 1998;15:47–51.Google Scholar
11.Modi, N, Damjanovic, V, Cooke, RWI. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit. Arch Dis Child 1987;62:148–151.Google Scholar
12.Friedland, IR, Funk, E, Khoosal, M, Klugman, KP. Increased resistance to amikacin in a neonatal unit following intensive amikacin usage. Antimicrob Agents Chemother 1992;36:1596–1600.CrossRefGoogle Scholar
13.Coovadia, YM, Johnson, AP, Bhana, RH, Hutchinson, GR, George, RC, Hafferjee, IE. Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks. J Hosp Infect 1992;22:197–205.CrossRefGoogle Scholar
14.Toltzis, P, Blumer, JL. Antibiotic-resistant gram-negative bacteria in the critical care setting. Pediatr Clin North Am 1995;42:687–702.Google Scholar
15.Hankin, GV, Chalas, E. Group-B streptococcal infections in pregnancy: ACOG's recommendations. American College of Obstetricians and Gynecologists (ACOG) Newsletter 1993;37:2.Google Scholar
16.Centers for Disease Control and Prevention. Prevention of perinatal group-B streptococcal disease: a public health prospective. MMWR 1996;45(RR-7):1–24.Google Scholar
17.Cordero, L, Davis, K, Morehead, S, Ayers, LW. Factors affecting microbial colonization of the trachea and septicemia in mechanically ventilated neonates. Respiratory Care 1993;38:1355–1363.Google Scholar
18.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;15:128–140.CrossRefGoogle Scholar
19.Cordero, L, Ayers, L, Davis, KNeonatal airway colonization with gram-negative bacilli: association with severity of bronchopulmonary dysplasia. Pediatr Infect Dis J 1997;16:18–23.CrossRefGoogle ScholarPubMed
20.Gaynes, RP, Edwards, JR, Jarvis, WR, Culver, DH, Toison, JS, Martone, WJ, et al. Nosocomial infections among neonates in high-risk nurseries in the United States. Pediatrics 1996;98:357–361.CrossRefGoogle ScholarPubMed
21.Appelbaum, PC, Beckwith, DG, Dipersio, JR, Dyke, JW, Salventi, JF, Stone, IX. Enhanced detection of bacteremia with a new BACTEC resin blood culture medium. J Clin Microbiol 1983;17:48–51.CrossRefGoogle ScholarPubMed
22.Wiswell, TE, Hachey, WE. Multiple site blood cultures in the initial evaluation for neonatal sepsis during the first week of life. Pediatr Infect Dis J 1991;10:365–369.Google Scholar
23.Gaynes, RP, Martone, WJ, Culver, DH, Emori, TG, Horan, TC, Banerjee, SN, et al. Comparison of rates of nosocomial infections in neonatal intensive care units in the United States. Am J Med 1991;91(3B):192S–196S.Google Scholar
24.Philip, AGS. The changing face of neonatal infection: experience at a regional medical center. Pediatr Infect Dis J 1994;13:1098–1102.Google Scholar
25.McDuffie, RS Jr, McGregor, JA, Gibbs, RS. Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage of premature rupture of the membranes and group-B streptococcus carriage. Obstet Gynecol 1993;82:487–489.Google ScholarPubMed
26.Hertz, DE, Denne, SC, Iiechty, EASepsis in asymptomatic term newborns delivered of antibiotic-treated mothers. J Perinatol 1994;6:446–449.Google Scholar
27.Joseph, TA, Pyati, SP, Jacobs, N. Neonatal early-onset Escherichia coli disease. Arch Pediatr Adolesc Med 1998;152:35–40.Google Scholar
28.American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group-B streptococcal infection by chemoprophylaxis. Pediatrics 1997;99:489–496.Google Scholar
29.Thompson, PJ, Greenough, A, Hird, MF, Philpott-Howard, J, Gamsu, HR. Nosocomial bacterial infections in very low birth weight infants. Eur J Pediatr 1992;151:451–454.Google Scholar
30.Kinney, JS, Johnson, KPapasian, C, Hall, RT, Kurth, CG, Jackson, MAEarly-onset Haemophilus influenzae sepsis in the newborn infant. Pediatr Infect Dis J 1993;12:739–743.Google Scholar
31.Drews, MB, Ludwig, AC, Leititis, JU, Daschner, FD. Low birth weight and nosocomial infection of neonates in a neonatal intensive care unit. J Hosp Infect 1995;30:65–72.Google Scholar
32.Soll, RF. Surfactant therapy in the USA: trials and current routines. Biol Neonate 1997;71(suppl 1):1–7.Google Scholar
33.1995 ASCP Susceptibility Testing Group. United States geographic bacterial susceptibility patterns. Am J Clin Pathol 1996;106:275–281.Google Scholar
34.White, RD, Townsend, TR, Stephens, MAMoxon, ERAre surveillance of resistant enteric bacilli and antimicrobial usage among neonates in a newborn intensive care unit useful. Pediatrics 1981;68:1–4.Google Scholar
35.Bryan, CS, John, JF, Pai, MS, Austin, TL. Gentamicin vs. cefotaxime for therapy of neonatal sepsis. Am J Dis Child 1985;139;1086–1089.CrossRefGoogle ScholarPubMed
36.Chow, JW, Fine, MJ, Shlaes, DM, Quinn, JRHooper, DC, Johnson, MP, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585–590.Google Scholar
37.Stratton, CW, Ratner, H, Johnston, PE, Schaffner, W. Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems. Diagn Microbiol Infect Dis 1992;15:11S–18S.CrossRefGoogle ScholarPubMed